Campomats
Italian company that designs and manufactures medical microneedling and micropigmentation devices for aesthetic medicine and dermatology, with proprietary patents and a presence in over 60 countries.
About Campomats
Campomats, Italian medical technology for microneedling and micropigmentation
Campomats is an Italian company based in Riccione (Rimini) dedicated to the design and manufacture of medical devices for aesthetic medicine and dermatology. Its activity focuses on microneedling and medical micropigmentation, with proprietary technology and international patents. The company presents itself as "The Medical Microneedling Experts" and combines research, innovation, and Italian manufacturing in its equipment.
The company states that its devices are medical-grade, certified in accordance with local regulations, and protected by international patents. Its offering includes solutions for skin regeneration, transdermal delivery, and complementary treatments such as exosomes, acne scars, and chemical peels.
Product lines and proprietary technologies
Campomats' catalog is organized around several families of devices and patented technologies:
- 1NEED Pro and 1NEED Proline: professional microneedling devices. The 1NEED Pro obtained FDA clearance in March 2025.
- NOFLOW®: patented anti-contamination system, presented by the company as the safest in the world in its category.
- RFNEED System: microneedling with bipolar radiofrequency and patented external technology, launched in September 2022.
- OMNIA: first medical device combining microneedling and dermopigmentation, presented in 2019.
- Starcolor inks: medical-grade pigments compliant with REACH for medical and cosmetic treatments.
The company also markets a skincare line with aloe vera and exosomes.
Medical micropigmentation and clinical applications
Campomats develops professional solutions for clinical micropigmentation, with REACH-compliant pigments and high-precision devices. These technologies are aimed at areola reconstruction in women who have undergone a mastectomy and the application of non-invasive fiducial markers in radiotherapy treatments. The company collaborates with hospitals, universities, and companies specialized in this field.
History and milestones
The company describes its evolution from its founding as an Italian start-up to its current position:
- 2019: OMNIA is born, the first medical device combining microneedling and dermopigmentation.
- 2020: first patent granted for PD/DS technology.
- 2021: launch of 1NEED.
- January 2022: registration of the NOFLOW® patent.
- September 2022: launch of RFNEED System.
- 2023: presentation of 1NEED Pro at IMCAS Paris.
- 2024: receives the Fondazione Italia USA award as one of the best Italian start-ups for innovation and internationalization; in the same month, Rotary International Italy grants it the Paul Harris Fellow Award for its humanitarian, social, and cultural commitment.
- March 2025: 1NEED Pro obtains FDA clearance.
Patents and certifications
Campomats holds more than ten granted international patents and three proprietary technologies: OMNIA, 1NEED, and RFNEED. Among the registered patents are the cartridge anti-reuse system (patents in Italy, the EU, the US, and Korea), IsoThermal Needling technology (Italian patent), and PD/DS needle penetration precision technology (patents in Italy, the EU, and the US). The company holds ISO 13485 and CE1370 certification.
International presence and collaborations
The company states it has a presence in over 60 countries and maintains collaborations with hospitals, universities, and specialized companies. Its section of collaborating experts includes dermatologists and plastic surgeons from Italy, Morocco, the United Kingdom, Honduras, Lebanon, and India, among others. Campomats also organizes webinars and publishes educational content on topics such as areola reconstruction after mastectomy, acne scars, photoaging, skin care after sun exposure, and hair growth.
Corporate profile
The company defines itself as a company that combines innovation, research, and proprietary patents with Italian manufacturing. Its approach includes the development of technologies for regenerative medicine and safe, comfortable treatments with natural-looking results. Campomats operates from its headquarters in Riccione and serves professionals in the medical and aesthetic sector, distributors, and patients.
Location and contact
Via Monte Rosa 11, 47838 Riccione (RN), Italy · Phone: +39 0541 317141 · Email: info@campomats.it
Medical microneedling and micropigmentation